U.S. SPACs that have completed their business combination — monthly close volume, post-merger price distribution, and the deals that just landed.
MTD closes
5
YTD closes
20
Avg announce → close
334d
120 pipeline
What counts as a DeSPAC
A SPAC that has completed its business combination — the formerly-blank-check shell now operates as the merged target. We count the close once the SEC filing confirms the merger consummated. The post-close share price is the most recent end-of-day close at the new ticker; values below $10 typically mean the deal closed at a discount to the SPAC's trust value.
History
Monthly DeSPAC closes
Trailing 13 months
7
4
4
4
4
0
4
1
2
7
1
4
5
Jun 25
Jul
Aug
Sep
Oct
Nov
Dec
Jan 26
Feb
Mar
Apr
May
Jun
Jun 25 → Jun 26
Post-close trading
Price distribution vs $10 trust
Last 12 mo · 37 priced
Latest close price for every DeSPAC that completed in the trailing 12 months and currently has a price feed. The $10 line is the SPAC's nominal trust value — closes below it mean the merged company trades at a discount.
SL Bio is a biomedical company focused on developing innovative cellular and gene therapies for cancer treatment and regenerative medicine. Leveraging proprietary technologies and strategic partnerships, the company is advancing next-generation immunotherapies and exosome-based products for both medical and consumer applications. SL Bio’s approach combines scientific expertise with a commitment to improving patient outcomes and addressing unmet needs in healthcare. SL Bio also offers ISO-certified, dermatologically tested cow milk-derived exosome-based products and plant extract products for skin and hair care, with commercial distribution in Asia.
Avalanche Treasury Co. (“AVAT”) is an ecosystem-aligned vehicle providing exposure to the Avalanche ecosystem through active treasury management, strategic investments, and an exclusive relationship with the Avalanche Foundation. AVAT bridges traditional finance and blockchain through a purpose-built operating system designed for institutional adoption.
At VERAXA Biotech, we are building a premier engine for the discovery and development of next-generation antibody-based therapeutics, including BiTAC antibody-drug conjugates (“BiTAC ADCs”), bispecific T cell engagers (“BiTAC TCEs”), and other innovative formats. Powered by a suite of transformative technologies and guided by rigorous quality-by-design principles, we are rapidly advancing our pipeline of ADCs and proprietary BiTAC formats into clinical development and beyond. VERAXA Biotech was founded on scientific breakthroughs made at the European Molecular Biology Laboratory (“EMBL”), a world-renowned institution known for pioneering life science research and cutting-edge technologies.
Founded in 2016, Einride is a technology company that develops and operates digital, electric and autonomous freight solutions to accelerate the transition to future proofed transportation in a cost-efficient way. Its technology platform includes AI powered planning and optimization, autonomous technologies, one of the world’s largest electric heavy-duty fleets and charging infrastructure. Einride is serving customers across North America, Europe and the Middle East.
Founded and headquartered in the Boston, Massachusetts, area, Factorial operates at the forefront of solid-state battery development, offering safe, high-performance alternatives to traditional lithium-ion technologies. Its proprietary FEST (Factorial Electrolyte System Technology) and Solstice platforms deliver greater energy density, enhanced safety, and compatibility with existing manufacturing systems. Factorial’s commercial partnerships include global automotive leaders such as Mercedes-Benz, Stellantis, Hyundai Motor Company, and Kia Corporation. Early investors include GVP Climate in partnership with Gatemore Capital Management and WAVE Equity Partners.
Hadron is a pioneer in MMR technology. Designed to deliver 10 MW of power, Hadron’s MMR will be smaller, more cost-effective, and faster to deploy than other proposed MMR power solutions. The revolutionary design of Hadron’s MMR allows its reactor core and containment shell to be transportable in a shipping container, providing a versatile deployment model for end users. Whether powering an artificial intelligence data center, remote community, or an industrial hub, Hadron’s MMR is expected to provide a reliable, safe and scalable nuclear energy solution.
Launched in 1999 and headquartered in Dubai, AIR is a global innovation leader in social inhalation, with a multinational presence in over 90 markets worldwide. Its portfolio of companies and assets includes Al Fakher, the world’s leading hookah brand; Hookah.com, North America’s number one B2B e-commerce platform for hookah and shisha by market share; and OOKA, highly innovative charcoal-free shisha device, among others. AIR’s science program, conducted in partnership with independent accredited laboratories, enables the development of innovative products that combine centuries of tradition with cutting-edge technology to minimize harm and maximize enjoyment for millions around the world.
Our enterprise-grade infrastructure delivers market-leading performance through strategic deployment of cutting-edge GPU architectures across top-tier data centers. By leveraging advanced interconnect technologies and bare metal provisioning, we provide institutional clients with the computational advantage needed to accelerate AI innovation while maintaining predictable cost structures and operational efficiency.
Enhanced is an elite sports competition and performance products company committed to giving athletes and people alike access to products that optimize their health, performance and recovery. The Enhanced Performance Product line provides consumers access to products, and protocols that optimize health, longevity and vitality. As a premium brand, Enhanced aims to revolutionize and lead the Performance Medicine category.
IPOs priced, votes called, deals closed, and redemptions tallied — the whole SPAC market, every morning. Published free on the site; get it in your inbox below.
Never miss a SPAC move.
Get the full brief in your inbox every market morning, or browse the complete archive of daily SPAC coverage.